93 related articles for article (PubMed ID: 6592845)
1. [The value of immunological studies in patients with malignant tumors of the maxillofacial region. 2: Determination of the immune complex concentration in the blood].
Teuber S; Gitt HA; Storch H
Stomatol DDR; 1984 Jul; 34(7):396-400. PubMed ID: 6592845
[No Abstract] [Full Text] [Related]
2. [Predictive value of immunological studies in patients with maxillofacial malignancies. 1. Leukocyte adherence inhibition tests (LAI)].
Teuber S; Storch H; Gitt HA
Stomatol DDR; 1984 May; 34(5):266-72. PubMed ID: 6382696
[No Abstract] [Full Text] [Related]
3. [The use of the determination of the immune competence of patients with malignant tumors of the maxillofacial area for making a diagnosis and prognosis].
Teuber S; Köhler M
Zahn Mund Kieferheilkd Zentralbl; 1989; 77(7):692-7. PubMed ID: 2532830
[TBL] [Abstract][Full Text] [Related]
4. [A survey of the cellular immunity in patients with malignant oral and maxillofacial tumors (author's transl)].
Chen WX
Zhonghua Kou Qiang Ke Za Zhi; 1981 Jun; 16(2):77-81. PubMed ID: 6949712
[No Abstract] [Full Text] [Related]
5. [Effect of combined treatment on T- and B-lymphocyte activity in tumors of the maxillofacial region of varying histological character].
Arsanov AA
Stomatologiia (Mosk); 1979; 58(4):37-9. PubMed ID: 314693
[No Abstract] [Full Text] [Related]
6. [Structural changes in the regional submandibular lymph nodes in malignant tumors of the maxillofacial area].
Kravchenko SV; Mikul'skaia SK
Stomatologiia (Mosk); 1983; 62(4):51-3. PubMed ID: 6578622
[No Abstract] [Full Text] [Related]
7. Immunological status of patients with denture stomatitis and yeast infection after treatment of maxillofacial tumors.
Spiechowicz E; Rusiniak-Kubik K; Skopińska-Rózewska E; Sokolnicka I; Zabuska-Jabłońska K; Brajczewska-Fischer W; Rolski D; Ciechowicz B; Gil M; Renner RP
Arch Immunol Ther Exp (Warsz); 1994; 42(4):263-7. PubMed ID: 7487364
[TBL] [Abstract][Full Text] [Related]
8. [A trial of establishing indications to surgical treatment of neoplasms on the basis of certain immunological parameters (author's transl)].
Kowalik S; Hałasa J; Dabrowski W; Braun J; Strzelecka G; Bobnis W
Otolaryngol Pol; 1981; 35(4-6):297-302. PubMed ID: 6979024
[No Abstract] [Full Text] [Related]
9. [Modifying action of autologous blood serum in the leukocyte adherence inhibition test in stomach cancer].
Kutrenkov OA; Miliukhina LM
Vopr Onkol; 1984; 30(7):81-5. PubMed ID: 6380104
[TBL] [Abstract][Full Text] [Related]
10. Immunological reactivity to soluble tumour extracts (STE) in gastrointestinal tumours and related risk groups.
Storch H; Raabe F; Krahl R; Liebe S; Hambsch K; Fischer H
Arch Geschwulstforsch; 1982; 52(1):57-61. PubMed ID: 7082132
[TBL] [Abstract][Full Text] [Related]
11. [The prevention of malignant tumors in the maxillofacial region].
Jurca M
Zobozdrav Vestn; 1975; 30(1-2):15-7. PubMed ID: 1076041
[No Abstract] [Full Text] [Related]
12. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
13. [Results of treatment of malignant tumors in the maxillofacial region].
Anastasov K; Kostov P
Stomatologiia (Sofiia); 1971; 53(2):87-100. PubMed ID: 5281427
[No Abstract] [Full Text] [Related]
14. [Complex therapy of malignant tumors in the orofacial region].
Bilder J
Cesk Stomatol; 1970 Sep; 70(5):264-8. PubMed ID: 5272062
[No Abstract] [Full Text] [Related]
15. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
16. [The content of cations and of total blood proteins of patients with tumors of the maxillofacial region].
Ermolaev II; Kulikova VS; Abdullaev MN
Stomatologiia (Mosk); 1973; 52(2):24-6. PubMed ID: 4513011
[No Abstract] [Full Text] [Related]
17. Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
Bhatti R; Shaw M; Ray P
Experientia; 1987 Aug; 43(8):916-7. PubMed ID: 3622734
[TBL] [Abstract][Full Text] [Related]
18. [The use of P32 in the surgical treatment of malignant oro-maxillofacial tumors].
Caldarola L; Badellino F; Del Fante FM; Roccia L; Del Boca R
Minerva Stomatol; 1966 Jul; 15(7):471-3. PubMed ID: 5224296
[No Abstract] [Full Text] [Related]
19. [Differential diagnosis of tumors and inflammation in the maxillofacial region].
Frenkel G
Zahnarztl Prax; 1983 Jul; 34(7):276-7. PubMed ID: 6582721
[No Abstract] [Full Text] [Related]
20. Evaluation of the LAI test in patients with benign and malignant breast diseases.
Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
